Workflow
财务造假
icon
Search documents
田野股份自曝财务造假背后:新式茶饮红利消退业绩“断崖” 私募基金陷关联交易接盘疑云
Xin Lang Zheng Quan· 2025-08-15 02:45
Core Viewpoint - Tianye Co., Ltd. is embroiled in a financial fraud scandal involving inflated revenues, manipulated costs, and misrepresented asset values, leading to significant financial restatements and potential delisting risks [1][2][3] Financial Performance - In 2024, Tianye's total profit was revised down from 34.08 million to 14.21 million, a decrease of approximately 58.3%, while net profit attributable to shareholders fell by 66.2% from 28.59 million to 9.65 million [2] - Revenue increased slightly by 7.3% compared to 2023, but net profit saw a dramatic decline of 71.5%, marking the lowest point since 2012 [2] - The company's revenue from core juice products accounted for 74.3% and 90.9% of total revenue in 2023 and 2024, respectively, but faced significant price pressures and declining margins [4][5] Client Dependency and Market Challenges - Major clients in the new-style tea beverage sector, such as Nayuki Tea and Tea Baidao, accounted for 82.9% of procurement, contributing significantly to revenue [2] - The competitive landscape has intensified, with major clients experiencing substantial losses, leading to reduced orders from Tianye [3][4] - The average price of mango juice dropped from 10,200 CNY/ton to 8,800 CNY/ton, while unit costs increased by 2%, resulting in a significant decline in gross margins [4][5] Governance and Investment Issues - Tianye established a private equity fund with Fangfu Venture Capital, but the fund's investment progress has raised concerns, with no direct project investments reported [6][7] - The fund's intended investment projects have been delayed, and there are questions regarding the legitimacy of certain transactions, including a questionable acquisition of shares in an unrelated biotech company [8][9] - Tianye has urged Fangfu to fulfill its capital contribution obligations by August 31, 2025, or risk exiting the fund [9]
60家上市公司集体暴雷!证监会连坐罚单首现,造假供应商被罚700万
Sou Hu Cai Jing· 2025-08-15 00:03
Core Viewpoint - The A-share market is experiencing a regulatory storm in 2025, highlighted by a series of violations by listed companies, notably the significant stock price drop of Hengxin Oriental, which reflects deep-seated financial issues and a loss of investor confidence [1] Group 1: Hengxin Oriental's Stock Price Collapse - Hengxin Oriental's stock opened down 17% on August 13, 2025, and further declined to 18.7%, resulting in a market value loss of 786 million yuan in a single day [1] - The company reported a cumulative net profit loss of 2.074 billion yuan from 2020 to 2024, with a 15% year-on-year revenue decline in Q1 2025 and an 11% increase in losses [1] - Financial discrepancies were revealed in the 2022 annual report, with revenue adjusted down from 492 million yuan to 310 million yuan, a reduction of 37% [1] Group 2: Broader Regulatory Actions - ST Gaohong was penalized for fabricating 19.8 billion yuan in revenue and fraudulently raising 1.25 billion yuan, leading to a 1.6 million yuan fine and a forced delisting process [3] - The regulatory crackdown has extended to the pharmaceutical sector, with five executives from Baiyunshan under investigation for inflating drug procurement prices and corruption [3] - Over 60 listed companies have been investigated for violations, with significant penalties imposed on executives, including ST Suwu, which inflated revenue by 1.98 billion yuan over four years [5][6] Group 3: Market Impact and Investor Reactions - The stock price of Jihua Group fell to the limit down after being formally investigated for information disclosure violations, indicating market skepticism despite the company's claims of normal operations [5] - By August 2025, 55 listed companies had been investigated for information disclosure violations, with penalties totaling 110.6 million yuan for nine companies and 58 executives [6] - Legal avenues for compensation have opened for investors who purchased shares during specific periods, with over 2,000 shareholders of Hengxin Oriental submitting trading records for claims [9]
“全链条追责”形成闭环!泽达易盛案三中介赔付5亿后起诉39名被告追偿3.7亿
Core Viewpoint - The lawsuit against 39 defendants, including Geer Software, seeks to recover 372 million yuan due to their alleged collusion in financial fraud with ZeDa YiSheng, a company that has already faced penalties for fraudulent issuance [1][3][4]. Group 1: Legal Proceedings and Financial Implications - Geer Software and 38 other defendants are being sued by three intermediary institutions for a total of 372 million yuan, which includes compensation for investor losses and penalties paid to the regulatory authority [1][3]. - The three intermediary institutions, Tianjian Accounting Firm, Dongxing Securities, and Kangda Law Firm, are pursuing claims of 127.46 million yuan, 215 million yuan, and 33 million yuan respectively [3]. - The lawsuit is part of a broader trend where third-party entities that assist in financial fraud are being held accountable, marking a shift towards comprehensive liability in capital market fraud cases [2][5]. Group 2: Regulatory Context and Market Impact - The China Securities Regulatory Commission (CSRC) has noted a new trend in financial fraud involving third-party collusion, which disrupts market order and necessitates strict enforcement [2][5]. - The CSRC has previously penalized ZeDa YiSheng for fraudulent activities, and the ongoing lawsuits aim to extend accountability to all parties involved in the fraud ecosystem [6][11]. - Experts suggest that this legal action could deter future collusion in financial fraud by increasing the costs associated with such activities, thereby promoting a more responsible market environment [7][10]. Group 3: Implications for Intermediaries and Third Parties - The lawsuit emphasizes the need for intermediaries to conduct thorough due diligence and shift from mere formal reviews to substantive risk assessments [7][8]. - Legal experts argue that third parties who knowingly assist in financial fraud pose a greater risk to the capital market than intermediaries who may act out of negligence [8][11]. - The outcome of this lawsuit could set a precedent for how third-party involvement in financial fraud is treated legally, potentially leading to stricter enforcement and accountability measures [10][11].
配合造假的第三方,正浮出水面
Jin Rong Shi Bao· 2025-08-14 01:46
一个多月内,中国证监会在其官网先后通报越博动力(现"越博退")、 *ST高鸿两例财务造假案件 处理情况。除上市公司及直接责任人被依法严惩外,引发各方关注的是,配合造假的第三方也被同步追 责。 "第三方主体配合、串通上市公司实施造假,双方乃至多方形成利益链、'生态圈',是近年来资本 市场财务造假的新特点,不仅扰乱市场秩序,且严重污染市场生态,必须予以严厉打击。"中国证监会 在通报中明确表示。 2024年以来,监管部门已多次明确严厉打击系统性造假和配合造假,并将第三方配合造假纳入惩治 范围,释放出严厉打击第三方造假的明确信号。 据《金融时报》记者不完全统计,今年内,因财务造假而被证监部门处罚或拟处罚的上市公司中, 8家涉及第三方公司配合虚构业务,包括ST诺泰、*ST苏吴、ST朗源、*ST广道、*ST恒久、*ST锦港、 ST智云、ST中青宝等。 第三方配合造假认定存诸多难点 梳理过往文件可以发现,第三方配合上市公司实施财务造假并非近年来才有的"新鲜"手段。据厦门 国家会计学院教授黄世忠统计,2019年至2023年,涉及客户、供应商、隐性关联方、金融机构等三方配 合造假的上市公司共计53家,多达541家第三方配合造假 ...
公司造假?董秘敲诈?安靠智电“吹哨人”疑案始末
Core Viewpoint - The ongoing legal dispute between Ankao Zhidian and its former secretary Huang Jiegen has reached a significant milestone with Huang being convicted of extortion, which he plans to appeal. The case highlights the complexities surrounding allegations of financial misconduct and the challenges of corporate governance in the Chinese market [1][2][3]. Group 1: Background of the Case - The conflict began in August 2022 when Huang questioned the authenticity of Ankao Zhidian's financial reports and refused to sign them, leading to accusations of extortion during negotiations for performance-based stock rewards [1][6][12]. - Huang's allegations of financial fraud were based on discrepancies in the company's reported profits, which he believed were inflated through premature revenue recognition [13][15][16]. Group 2: Legal Proceedings - Huang was arrested on July 28, 2023, during a court hearing related to his administrative lawsuit against the regulatory bodies for not investigating the alleged financial fraud [2][3]. - The court's ruling on August 11, 2023, found Huang guilty of extortion, with the sentence expected to be severe, although details remain undisclosed as he intends to appeal [1][4]. Group 3: Financial Allegations - Huang reported that Ankao Zhidian had inflated its profits by 44% in the 2021 semi-annual report and by 64.5% in the annual report, primarily through the early recognition of revenue from a project that had not yet generated actual income [15][16]. - The company’s financial performance has deteriorated significantly, with its stock price dropping by 60% since its peak in November 2021, reflecting a loss of investor confidence [24]. Group 4: Company and Industry Impact - Ankao Zhidian, which specializes in cable connection systems and gas-insulated transmission systems, has faced severe scrutiny and regulatory actions due to the allegations of financial misconduct [12][16]. - The ongoing legal battle and the company's declining stock performance have led to a significant reduction in institutional investor holdings, from 15.3% to 2.1%, indicating a loss of market trust [24].
富二代辞职接班潮:沈家雯接任力源科技董事长
Sou Hu Cai Jing· 2025-08-13 13:50
· · · 这届富二代,有的早早进入自家公司历练,一路升到管理层,方便接老一辈的班。 有的呢,不喜欢自家公司的生意,就带资进组去投行,甚至直接开投资公司搞项目,想做什么行业就做 什么行业。 也有的富二代,简直是别人家的孩子,经历了高考进了名校,毕业之后实打实找工作上班,进入券商、 基金等光鲜亮丽的公司,还干到了中层。结果呢,家里老爹出事,一个电话打来,又得辞了职回去撑起 自己家公司。 二代要想好好上个班,也不容易啊。 近日,科创板上市公司力源科技发布公告,董事长沈万中因个人原因申请辞职,同时,公司董事会已提 名沈家雯为第四届董事会非独立董事候选人,任期自股东大会审议通过之日起至第四届董事会任期届满 为止。 沈家雯系公司控股股东、实控人沈万中之女。 截至公告披露日,沈家雯直接持有力源科技股份140万股,占公司总股本的比例为0.94%。另外,沈万 中直接持有力源科技股份4806.2万股,占公司总股本比例为32.10%。 有的富二代,经历了高考进了名校,毕业之后实打实找工作上班,还干到了中层。结果呢,家里老爹出 事,一个电话打来,又得辞了职回去撑起自己家公司。二代要想好好上个班,也不容易啊。 文丨金融八卦女特约作者 ...
泽达易盛财务造假案余波未平 引发连环索赔诉讼
Mei Ri Jing Ji Xin Wen· 2025-08-13 12:26
Core Viewpoint - The financial fraud case involving Zeda Yisheng continues to have repercussions, leading to a series of compensation lawsuits against Geer Software and other involved parties [2][3]. Group 1: Legal Proceedings - Geer Software has received notifications from the Shanghai Financial Court regarding lawsuits filed by Tianjian Accounting, Dongxing Securities, and Kangda Law Firm, seeking compensation for losses [3]. - The three intermediary institutions are pursuing claims against 37 companies and 2 individuals, requesting a total of approximately 1.23 billion yuan, 2.15 billion yuan, and 0.33 billion yuan in principal and interest [3]. - Zeda Yisheng was previously penalized by the China Securities Regulatory Commission for fraudulent issuance and information disclosure violations, leading to a total compensation payout of about 493 million yuan to investors [2][3]. Group 2: Financial Impact - Geer Software stated that the ongoing lawsuits have not yet gone to trial, making it difficult to assess their impact on the company's current or future profits [4]. - The transactions involved in the lawsuits were determined to have a minor effect on the accuracy of Geer Software's financial statements from 2018 to 2021, thus no retrospective adjustments are necessary [4]. Group 3: Historical Context - Geer Software's historical announcements reveal that the company inflated its net profit by 2.75 million yuan, 2.51 million yuan, and 773,800 yuan from 2018 to 2020, while reducing its net profit by 1.90 million yuan in 2021 [5]. - The Shanghai Securities Regulatory Bureau issued a warning letter to Geer Software and related personnel in 2023 regarding these financial discrepancies [5]. Group 4: Legal Framework and Defense - Legal experts indicate that for the intermediary institutions to exercise their right of recourse, they must prove that the parties being pursued had faults and that there is a direct causal relationship between their actions and the damages incurred [6]. - The concept of "no commercial substance" in transactions may not be sufficient for a successful claim unless it can be shown that the involved parties knowingly participated in fraudulent activities [7]. Group 5: Risk Mitigation Strategies - Geer Software is taking proactive measures to strengthen the understanding of relevant laws and regulations among its directors, supervisors, and senior management [8]. - The company is also enhancing its internal control systems to improve operational compliance and risk identification capabilities [8].
公司造假?董秘敲诈?安靠智电“吹哨人”疑案始末
凤凰网财经· 2025-08-13 10:19
Core Viewpoint - The ongoing legal dispute between the listed company Ankao Zhidian and its former secretary Huang Jiegen has reached a significant milestone, with Huang being convicted of extortion, which he plans to appeal. The case highlights the complexities of corporate governance and financial integrity within the company [1][3]. Group 1: Background of the Dispute - The conflict began in August 2022 when Huang Jiegen questioned the authenticity of Ankao Zhidian's financial reports and refused to sign them, leading to accusations of extortion when he sought stock rewards as per a performance agreement [1][5]. - Huang's apprehension stemmed from concerns about potential retaliation for his insistence on truthful reporting, prompting him to submit a written opinion indicating he could not guarantee the accuracy of the financial statements [8][9]. - The performance agreement stipulated that Huang would receive stock rewards contingent on the company's market value meeting specific targets over three years, alongside commitments to maintain a minimum profit growth [9][10]. Group 2: Financial Misconduct Allegations - Huang raised alarms about potential financial misconduct after noticing discrepancies in the company's profit figures across different versions of financial reports, leading him to suspect that profits were artificially inflated [17][21]. - He reported that the company had prematurely recognized revenue from a project, which he believed had not generated any actual income, resulting in significant profit inflation in the financial statements [19][21]. - Huang filed multiple complaints with the China Securities Regulatory Commission regarding the alleged financial fraud, but the regulatory response was limited, leading to dissatisfaction with the outcomes [22][23]. Group 3: Legal Proceedings and Outcomes - The legal proceedings have been marked by delays and conflicting narratives from both parties, with Huang portraying himself as a whistleblower while the company accused him of premeditated extortion [1][23]. - The court's ruling on Huang's conviction for extortion has raised questions about the nature of his demands, which he argues were legitimate claims for owed compensation rather than illegal extortion [5][26]. - The case reflects broader issues of corporate governance, accountability, and the protection of whistleblowers in the financial sector, with implications for investor confidence in Ankao Zhidian [27][30].
卷入3.7亿元索赔官司,格尔软件否认故意配合泽达易盛造假
Hua Xia Shi Bao· 2025-08-13 09:57
Core Viewpoint - The aftermath of the notorious Zeda Yisheng financial fraud case continues, with three intermediary institutions seeking to recover approximately 370 million yuan from 39 defendants after compensating investors [2][3]. Group 1: Zeda Yisheng Fraud Case Overview - Zeda Yisheng, a significant case in the STAR Market, was found to have fabricated major false content and concealed important facts in its prospectus and multiple annual reports, resulting in inflated revenue of 565 million yuan and inflated profits of 296 million yuan from 2016 to 2021 [3]. - The China Securities Regulatory Commission (CSRC) imposed a warning and fines totaling 86 million yuan on Zeda Yisheng and its responsible individuals, leading to the company's delisting from the Shanghai Stock Exchange on July 7, 2023 [3][4]. - A special representative lawsuit was initiated in July 2023, resulting in a settlement where 7,195 eligible investors received 285 million yuan in compensation, marking the first collective lawsuit involving a STAR Market company [4]. Group 2: Involvement of Intermediary Institutions - Dongxing Securities, Tianjian Accounting Firm, and Kangda Law Firm, all involved in Zeda Yisheng's IPO, previously compensated investors approximately 493 million yuan and are now pursuing recovery from other responsible parties [5]. - The total claims against the defendants, including Ger Software, amount to approximately 370 million yuan, with Dongxing Securities seeking about 215 million yuan, Tianjian Accounting Firm about 120 million yuan, and Kangda Law Firm about 33.45 million yuan [6]. Group 3: Ger Software's Position - Ger Software, listed on the Shanghai Stock Exchange, was implicated due to its involvement in non-commercial transactions with Zeda Yisheng, leading to inaccuracies in its financial reports from 2018 to 2021 [6][7]. - The company has stated that it did not intentionally cooperate with Zeda Yisheng's fraudulent activities and is taking the lawsuit seriously, engaging a legal team to respond effectively [7].
华熙生物前高管45万字手撕“玻尿酸女王”,“财务造假”内幕曝光
商业洞察· 2025-08-13 09:24
Core Viewpoint - Huaxi Biological is facing serious allegations of financial misconduct, including accusations of financial fraud and inflated revenue figures, which have led to a significant decline in its stock price and raised concerns about its governance and internal conflicts [3][4][29]. Group 1: Allegations and Responses - A former employee, David, has accused Huaxi Biological's controlling shareholder, Huaxi Xinyu Investment Co., of concealing shareholdings and committing fraud related to bond issuance and revenue inflation [3][4]. - Huaxi Biological has publicly responded, stating that David was previously a market director who committed fraud and was reported for embezzlement [3][24]. - The company claims that David's allegations were investigated during its IPO process in 2019 and were found to be unsubstantiated [3][29]. Group 2: Financial Data Discrepancies - Significant discrepancies in financial data have been highlighted, with David pointing out that the revenue for the first half of 2017 was reported at 278 million RMB, which was 91 times the total revenue for the entire year [11][14]. - The company's financial reports show a dramatic increase in operating income and expenses in 2017, followed by a sharp decline in the annual report, raising red flags about the accuracy of the financial statements [12][20]. - David alleges that the inflated figures were linked to profits from the sale of shares in Jinju Holdings, which were then misclassified as operational costs to reduce tax liabilities [14][16]. Group 3: Internal Conflicts and Governance Issues - Huaxi Biological has faced multiple internal disputes, including allegations of stock buybacks at undervalued prices and conflicts among founding members regarding profit-sharing [34][36]. - The company has been criticized for its governance practices, with frequent reports of employee grievances and accusations of workplace bullying [34][36]. - Recent financial performance has shown a decline, with a reported 11.6% drop in revenue and a 70.6% decrease in net profit for 2024, indicating potential underlying issues within the company [34][36].